尚荣医疗收盘下跌7.71%，滚动市盈率167.49倍，总市值37.46亿元

Core Insights - The company, Shangrong Medical, closed at 4.43 yuan on August 14, experiencing a decline of 7.71%, with a rolling PE ratio of 167.49 times and a total market capitalization of 3.746 billion yuan [1][2] - The average PE ratio in the medical device industry is 55.76 times, with a median of 39.14 times, placing Shangrong Medical at the 112th position in the industry ranking [1][2] - As of March 31, 2025, the number of shareholders in Shangrong Medical is 58,323, a decrease of 621 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares per shareholder [1] Company Overview - Shangrong Medical specializes in the production and sales of medical products, medical services, and health industry operations [1] - The company is recognized as one of the earliest to introduce clean technology into hospital operating rooms and has received multiple honors, including national key new product recognition and a second-class award for scientific and technological progress from the Shenzhen government [1] - Shangrong Medical is classified as a national high-tech enterprise and has accumulated over 180 patents, which serve as a driving force for its continuous development [1] Financial Performance - In the first quarter of 2025, the company reported an operating income of 280 million yuan, a year-on-year increase of 1.30%, and a net profit of 13.9642 million yuan, reflecting a year-on-year growth of 0.58% [2] - The sales gross margin for the same period was recorded at 15.27% [2]